medigraphic.com
ISSN 1729-519X (Print)

2019, Number 1

<< Back Next >>

Revista Habanera de Ciencias Médicas 2019; 18 (1)

Comorbidity in patients with the diagnosis of Arterial Hypertension admitted to Internal Medicine wards

Shunchao K, Xueqing L, Blanco AMÁ, Bacallao GJ

Language: Spanish
References: 35
Page: 45-59
PDF size: 633.22 Kb.


ABSTRACT

Introduction: Comorbidity, as a problem in the practice of the medical profession, implies greater complexity in terms of diagnosis, treatment, creation of care protocols, and research. It is necessary to identify comorbidity in the hypertensive patient treated in internal medicine wards and establish etiopathogenic, pathophysiological, and therapeutic mechanisms.
Objective: To identify the magnitude of comorbidity in patients with arterial hypertension admitted to the Internal Medicine wards.
Material and Methods: A descriptive and prospective research was carried out on 144 hypertensive patients. The necessary information was collected from medical interviews, patients´ clinical exams, clinical histories, and case discussions with the doctors that were providing medical care to these patients. The data obtained were recorded in the database of Statistical Package SPSS software version 11.5.
Results: The most frequent comorbidities were type 2 diabetes mellitus in a 72.9%; ischemic heart disease in a 54.9%, and cerebrovascular disease in a 36.1%.
Conclusions: The magnitude of comorbidity in hypertensive patients admitted to Internal Medicine Wards recognizes Type 2 Diabetes Mellitus and atherosclerotic complications derived from both entities, as the most relevant pathophysiological associations.


REFERENCES

  1. Caughey GE, Vitry AI, Gilbert AL, Roughead EE. Prevalence of comorbidity of chronic diseases in Australia. BMC Public Health [Internet].2008 Jun [cited 20/03/2018]; 8:49. Available from: https://bmcpublichealth.biomedcentral.com/art icles/10.1186/1471-2458-8-221

  2. Harrison C, Henderson J, Miller G, Britt H. The prevalence of complex multimorbidity in Australia. Aust N Z J Public Health [Internet].2016 Jun [cited 8/03/2018]; 40(3):239-43. Available from: https://onlinelibrary.wiley.com/doi/10.1111/17 53-6405.12509

  3. Quiñones AR, Markwardt S, Botoseneanu A. Multimorbidity combinations and disability in older adults. J Gerontol A Biol Sci Med Sci [Internet].2016 Jun [cited 8/03/2018];71(6):[about 35 p.]. Available from: https://academic.oup.com/biomedgerontology/ article/71/6/823/2465786

  4. Liu J, Ma J, Jiaojiao W, Zeng DD, Song H, Wang L, et al. Comorbidity Analysis According to Sex and Age in Hypertension Patients in China. Int. J. Med. Sci. [Internet]. 2016 [cited 8/03/2018]; 13(2):99-107. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PM C4764775/pdf/ijmsv13p0099.pdf.

  5. Rivera Arango A, Ríos Osorio LA, Cardona Arias JA, Jaiberth A. Perfil de comorbilidad de pacientes hipertensos de una ese del área metropolitana de Medellín, Colombia 2013. Investigaciones Andinas [Internet]. 2016 [citado 21/03/2018];18(32):1521-36. Disponible en: https://www.google.com.cu/url?sa=t&rct=j&q= &esrc=s&source=web&cd=2&ved=0ahUKEwisyJ 3Uor_aAhXwg- AKHT7dBJgQFggtMAE&url=http%3A%2F%2Fww w.redalyc.org%2Fpdf%2F2390%2F23904731800 7.pdf&usg=AOvVaw0HanRu7R3RFdTGXvUJq39e

  6. Kou S, Li X, Blanco Aspiazu MÁ. Mecanismos de comorbilidad en hipertensión arterial. Rev Haban de Cienc Méd [Internet]. 2018 [citado 12/03/ 2018];17(1): Disponible en: http://www.revhabanera.sld.cu/index.php/rhab /article/view/2179/1968

  7. Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, e Boer IH, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care [Internet]. 2015 Sep [cited 21/03/2018];38(9):[about 80 p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PM C4876675/.

  8. Cabandugama PK, Gardner MJ, Sowers JR. The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardio renal Metabolic Syndrome (CRS). Med Clin North Am [Internet]. 2017 Jan [cited 21/03/2018]; 10(1):129-137. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PM C5125542/pdf/nihms811834.pdf.

  9. Pérez-Tasigchana RF, León-Muñoz LM, Lopez- Garcia E, Gutierrez-Fisac JL, La claustra M, Rodríguez-Artalejo F, et al. Metabolic syndrome and insulin resistance are associated with frailty in older adults: a prospective cohort study [abstract]. Age and Ageing [Internet].2017 Sep [cited 21/03/2018];46(5):[about 2 p.]. Available from: https://academic.oup.com/ageing/articleabstract/ 46/5/807/3058771.

  10. González-Quevedo A, González-García S, Peña-Sánchez M, Menéndez-Saínz C, Fernández- Carriera R, Cordero-Einz A. Blood-Based Biomarkers Could Help Identify Subclinical Brain Damage Caused by Arterial Hypertension. MEDICC Review [Internet]. 2016 Jan-Apr [cited 21/03/2018]; 18(1-2):46-56. Available from: http://www.medigraphic.com/pdfs/medicrevie w/mrw-2016/mrw161_2j.pdf

  11. Aksit E, Gursul E, Aydin F, Samsa M, Ozcelik F. Non-dipper hypertension is associated with slow coronary flow among hypertensive with normal coronary angiogram. PMC [Internet]. 2017 Jan- Feb [cited 21/03/2018];28(1):14-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PM C5423430/

  12. Jun Y, Xin-Rong Z, Si-Ping H, Hong C, Lan W, Jin-Wei W, et al. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE). BMC Nephrol [Internet].2017 Jan [cited 2018 Mar 21];18:1-12. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PM C5237491/pdf/12882_2017_Article_441.pdf.

  13. Sharma R, Kamalakar S, McCarthy E, Fields TA, Gupta K, Barua R, et al. Proteinuria in Hypertensive Nephropathy: A Review. Open J Nephrol [Internet]. 2014 Jun [cited 21/03/2018];2(2):92-9. Available from: https://www.scirp.org/journal/PaperInformatio n.aspx?paperID=47231

  14. Santana Téllez TN, Monteagudo Canto A, Del Águila Grandez AY, Vázquez Gamboa A. Eficacia de la microdosis de captopril en el tratamiento de la hipertensión arterial esencial. Rev cubana med [Internet]. 2012 Jul-Sep [citado 21/03/2018];15(3):247-57. Disponible en: http://scielo.sld.cu/pdf/med/v51n3/med06312. pdf

  15. Morales SA, Pérez BK, Villanueva RY. Hipertensión arterial refractaria y la espironolactona. Análisis del ensayo clínico PATHWAY 2. Rev. Finlay [Internet]. 2016 Sep-Dic [citado 21/03/2018];6(3):256-9. Disponible en: http://scielo.sld.cu/pdf/rf/v6n3/rf10306.pdf

  16. Furones Mourelle JA, Druyet Castillo D, López Aguilera ÁF, Cruz Barrios MA, Jiménez LG. Reacciones adversas no descritas en embarazadas de Cuba. Rev Cubana Farm [Internet]. 2015 Abr-Jun [citado 21/03/2018];49(2):291-303. Disponible en: http://scielo.sld.cu/pdf/far/v49n2/far09215.pdf

  17. Jiménez López G, Ramón Fabregas L, Gil Medina S, Delgado Blanca E, Avila PJ. Cruce de datos de calidad y seguridad de medicamentos nacionales a partir de bases de datos automatizadas: Primer semestre 2006. Rev Cubana Farm [Internet]. 2007 Sep-Dic [cited 21/03/2018];41(3):6-1. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext &pid=S0034-75152007000300005

  18. Hernández Vázquez LM, Pérez Martínez VT, de la Vega Pažitková T, Alfonso Montero OA, Edgardo Quijano J. Caracterización de pacientes hipertensos mayores de 18 años del consultorio médico 3 del Policlínico Docente" Ana Betancourt". Rev Cubana Med Gen Integr [Internet]. 2014 Ene-Mar [citado 21/03/2018]; 30(1):59-70. Disponible en: http://scielo.sld.cu/pdf/mgi/v30n1/mgi06114.pd f

  19. García Orihuela M, Abreu Valdez I, Ruíz Salvador AK, Espinosa Martínez J, Salinas González TM. Prescripción farmacológica en ancianos hipertensos hospitalizados. Rev Cubana Farm [Internet]. 2013 Dic [citado 21/03/2018];47(4):475-82. Disponible en: http://scielo.sld.cu/pdf/far/v47n4/far07413.pdf

  20. Pérez Caballero MD, León Álvarez JL, Dueñas Herrera A, Alfonzo Guerra JP, Navarro Despaigne DA, De la Noval García R, et al. Guía cubana de diagnóstico, evaluación y tratamiento de la hipertensión arterial [Suplemento especial]. Rev Cubana Med [Internet]. 2017 [citado 21/03/2018]; 56(sup):[aprox. 67 p.]. Disponible en: http://bvs.sld.cu/revistas/med/vol56_sup_17/su mario.htm

  21. Corona MM, Barceló Acosta M, González RG, Blanco DR. Circunferencia de la cintura, tamaño de la grasa visceral y trastornos metabólicos en la obesidad mórbida. Rev Cubana Alim Nutr. [Internet]. 2015 Jun [citado 18/04/2018];25(1):28-47. Disponible en: http://www.medigraphic.com/pdfs/revcubalnut /can-2015/can151e.pdf

  22. Ozhan H, Alemdar R, Caglar O, Ordu S, Kaya A, Albayrak S, et al. MELEN Investigators. Performance of bioelectrical impedance analysis in the diagnosis of metabolic syndrome. Journal of Investigative Medicine. [Internet].2012 Mar [cited 12/06/2018];60(3):587-91. Available from: https://jim.bmj.com/content/60/3/587.full.pdf

  23. Incalzi RA, Capparella O, Gemma A, Landi F, Bruno E, Di Meo F, et al. The interaction between age and comorbidity contributes to predicting the mortality of geriatric patients in the acute-care hospital. Journal of Internal [Internet].1997 Oct [cited 12/02/2018];241(4):291-8. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1046 /j.1365-2796.1997.00132.x

  24. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index.JClinEpidemiol.[Internet].1994Nov [cited 8/03/2018];47(11):[about 6 p.]. Available from: https://www.sciencedirect.com/science/article/ pii/0895435694901295/pdf?md5=4fa4638830f8 2abe14c6b59f951cb248&pid=1-s2.0- 0895435694901295-main.pdf

  25. Calderín Bouza RO, Orlandi GN. Síndrome metabólico vs síndrome de insulino resistencia. Diferentes términos, clasificaciones y enfoques: ¿existe o no? Rev Cubana Endocrinol [Internet]. 2006 Dic [citado 16/04/2018]; 17(3 ):[about 5 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext &pid=S1561-29532006000300006&lng=es.

  26. Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes – Mechanisms, Management, and Clinical Considerations. Circulation [Internet]. 2016 [cited 2018 Feb20]; 133(24):2459-2502. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PM C4910510/.

  27. Rapsomaniki E, Timmis A, George J, Pujades- Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1•25 million people. Lancet [Internet]. 2014 May [cited 14/06/2017]; 383(9932): [about 1899-1911 p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PM C4042017/.

  28. Vardeny O, Nicholas G, Andrei A, Buhr KA, Hermanson MP, Moran JJ, et al. Β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol. American Journal of Hypertension [Internet]. 2012 [cited 28/07/2017]; 25(8): [about 920-926 p.]. Available from: https://experts.umn.edu/en/publications/%CE% B2-ar-polymorphisms-and-glycemic-and-lipidparameters- in-hypertens

  29. Proenza-Fernández L, Núñez-Ramírez L, de-la- Paz-Castillo K, Ortiz-Velasco M, Fuoman-Linares Y. Caracterización de los factores de riesgo en pacientes con Enfermedad Cerebrovascular. MULTIMED Granma [Internet]. 2017 [citado 20/04/2017];16(4). Disponible en: http://www.revmultimed.sld.cu/index.php/mtm /article/view/596

  30. Sevilla A. Características clínicas y epidemiológicas de pacientes menores de 45 años con enfermedad cerebrovascular. Ciudad Hospitalaria “Dr. Enrique Tejera” Valencia edo. Carabobo 2004-2011 [tesis especialidad en Internet]. Valencia: Universidad de Carabobo Facultad de Ciencias de la Salud; 2017 [citado 24/12/2017]; 34. Disponible en: http://riuc.bc.uc.edu.ve/bitstream/123456789/4 947/1/asevilla.pdf

  31. Sandoya E. Diabetes y enfermedad cardiovascular en Uruguay. Rev Urug Cardiol [Internet]. 2016 Dic [citado 25 Ago 2017]; 31(3):505-14. Disponible en: http://www.scielo.edu.uy/pdf/ruc/v31n3/v31n3 a12.pdf

  32. Marín Barrera L, Jara Palomares L, Blasco Esquivias I, Rodríguez Matute C, Fernández Capitán C, López Reyes R, et al. Los estudios prospectivos de pacientes consecutivos con enfermedad tromboembólica venosa no identifican a todos los pacientes en riesgo. Análisis multicéntrico ambispectivo del grupo contaminatep. Rev Esp Patol Torac [Internet]. 2016 [citado 24 Ago 2017]; 28(1):29-37. Disponible en: https://www.neumosur.net/files/publicaciones/ Revistas/2016/3_original-revista2016v28n1.pdf

  33. León DC, Agudelo AM, Ramos J, Ibarra MD. Caracterización clínica del síndrome nefrótico en infantes de Neiva. R.F.S Rev Facul Sal [Internet]. 2015 Ene-Jun [citado 17/04/2018]; 7(1):9-16. Disponible en: https://www.journalusco.edu.co/index.php/rfs/ article/view/174

  34. Sharma R, Kamalakar S, McCarthy E, Fields TA, Gupta K, Barua R, et al. Proteinuria in Hypertensive Nephropathy: A Review. Open J Nephrol [Internet]. 2014 Jun [cited 21/03/2018];2(2):92-9. Available from: http://www.scirp.org/journal/PaperDownload.a spx?paperID=47231

  35. Araújo L, Betancourt B, Dos Santos G, González V, VasquesL, Vignolo W, et al. La Hipertensión Arterial es factor de riesgo para el desarrollo y progresión de la Enfermedad Renal Crónica. Rev. Urug. Med. Int. [Internet]. 2016 Dic [citado 10/03/2018];1(3):4-13. Disponible en: http://www.scielo.edu.uy/pdf/rumi/v1n3/v01n0 3a01.pdf




2020     |     www.medigraphic.com